Cargando…

Long-term outcomes of monascin – a novel dual peroxisome proliferator-activated receptor γ/nuclear factor-erythroid 2 related factor-2 agonist in experimental intracerebral hemorrhage

BACKGROUND: Hematoma is the chief culprit in brain injury following intracranial cerebral hemorrhage (ICH). Noninvasive hematoma clearance could be an option to prevent and alleviate early brain injury after ICH. Peroxisome proliferator-activated receptor γ (PPAR-γ) and nuclear factor-erythroid 2 re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Pengcheng, Liu, Jiachen, Bai, Qinqin, Sun, Xingang, Yao, Zhenjia, Liu, Lirong, Wu, Cuimei, Wang, Gaiqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Therapeutic Perspectives in Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232052/ https://www.ncbi.nlm.nih.gov/pubmed/32477427 http://dx.doi.org/10.1177/1756286420921083

Ejemplares similares

Neuroprotection by Nrf2 via modulating microglial phenotype and phagocytosis after intracerebral hemorrhage
por: Liang, Chuntian, et al.
Publicado: (2023)

Mechanisms of Oxidative Stress and Therapeutic Targets following Intracerebral Hemorrhage
por: Yao, Zhenjia, et al.
Publicado: (2021)

Microglia: A Double-Edged Sword in Intracerebral Hemorrhage From Basic Mechanisms to Clinical Research
por: Liu, Jiachen, et al.
Publicado: (2021)

Ferroptosis, a Regulated Neuronal Cell Death Type After Intracerebral Hemorrhage
por: Bai, Qinqin, et al.
Publicado: (2020)

Regulation of nuclear factor erythroid-2-related factor 2 as a potential therapeutic target in intracerebral hemorrhage
por: Zhang, Yuan, et al.
Publicado: (2022)

Monascin accelerates anoikis in circulating tumor cells and prevents breast cancer metastasis
por: Chen, Kung-Yen, et al.
Publicado: (2020)

Inhibition of human chondrosarcoma cell growth via apoptosis by peroxisome proliferator-activated receptor-γ
por: Nishida, K, et al.
Publicado: (2002)

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
por: Wang, Limei, et al.
Publicado: (2014)

Role of Tiotropium in Reducing Exacerbations of Chronic Obstructive Pulmonary Disease When Combined With Long‐Acting β (2)‐Agonists and Inhaled Corticosteroids: The OUTPUL Study
por: Ferroni, Eliana, et al.
Publicado: (2016)

Monascin abrogates RANKL-mediated osteoclastogenesis in RAW264.7 cells via regulating MAPKs signaling pathways
por: Cheng, Yin, et al.
Publicado: (2022)

Factors Influencing Change in Serum Uric Acid After Administration of the Sodium‐Glucose Cotransporter 2 Inhibitor Luseogliflozin in Patients With Type 2 Diabetes Mellitus
por: Chino, Yukihiro, et al.
Publicado: (2021)

Monascin ameliorate inflammation in the lipopolysaccharide-induced BV-2 microglial cells via suppressing the NF-κB/p65 pathway
por: Shi, Yong-Xiang, et al.
Publicado: (2020)

Elevated serum nuclear factor erythroid 2-related factor 2 levels contribute to a poor prognosis after acute supratentorial intracerebral hemorrhage: A prospective cohort study
por: Wang, Chuan-Liu, et al.
Publicado: (2022)

Evaluation of the Prevalence and Risk Factors of Drug-Related Problems in Hypertension and Type 2 Diabetes Mellitus Patients at a Tertiary Care Hospital: A Cross-Sectional Study
por: Reddy Peddi, Divya, et al.
Publicado: (2023)

The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model
por: Sandström, M, et al.
Publicado: (2004)

Is Nuclear Factor Erythroid 2-Related Factor 2 a Target for the Intervention of Cytokine Storms?
por: Liu, Zihang, et al.
Publicado: (2023)

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
por: Li, Jingjing, et al.
Publicado: (2021)

Role of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy
por: Cui, Wenpeng, et al.
Publicado: (2017)

Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism
por: Smolková, Katarína, et al.
Publicado: (2020)

Metals of Deep Ocean Water Increase the Anti-Adipogenesis Effect of Monascus-Fermented Product via Modulating the Monascin and Ankaflavin Production
por: Lung, Tzu-Ying, et al.
Publicado: (2016)

Haematoma scavenging in intracerebral haemorrhage: from mechanisms to the clinic
por: Wang, Gaiqing, et al.
Publicado: (2017)

Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?
por: Dolley-Hitze, T, et al.
Publicado: (2010)

Effects of GLP‐1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta‐analysis
por: Kelly, Michael, et al.
Publicado: (2022)

COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
por: Timoshenko, A V, et al.
Publicado: (2006)

Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma
por: BO, QI-FU, et al.
Publicado: (2015)

Multi-Omics Analysis in Initiation and Progression of Meningiomas: From Pathogenesis to Diagnosis
por: Liu, Jiachen, et al.
Publicado: (2020)

Corrigendum: Multi-Omics Analysis in Initiation and Progression of Meningiomas: From Pathogenesis to Diagnosis
por: Liu, Jiachen, et al.
Publicado: (2020)

Identification of a Small Molecular Insulin Receptor Agonist With Potent Antidiabetes Activity
por: Qiang, Guifen, et al.
Publicado: (2014)

Involvement of nuclear factor erythroid 2-related factor 2 in neonatal intestinal interleukin-17D expression in hyperoxia
por: Liu, Xuying, et al.
Publicado: (2020)

PPAR-γ Promotes Hematoma Clearance through Haptoglobin-Hemoglobin-CD163 in a Rat Model of Intracerebral Hemorrhage
por: Wang, Gaiqing, et al.
Publicado: (2018)

Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer
por: Xiang, R, et al.
Publicado: (2011)

The role of nuclear factor erythroid-2-related factor 2 expression in radiocontrast-induced nephropathy
por: Kim, Ji Eun, et al.
Publicado: (2019)

Quinolinic Acid and Nuclear Factor Erythroid 2-Related Factor 2 in Depression: Role in Neuroprogression
por: Bansal, Yashika, et al.
Publicado: (2019)

Nuclear Factor Erythroid-2-Related Factor 2 Signaling in the Neuropathophysiology of Inherited Metabolic Disorders
por: Seminotti, Bianca, et al.
Publicado: (2021)

Role of Nuclear Factor Erythroid 2‒Related Factor 2 in Chronic Obstructive Pulmonary Disease
por: Ban, Woo Ho, et al.
Publicado: (2022)

The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer
por: Xia, Lei, et al.
Publicado: (2023)

Relationship between oxidative stress and nuclear factor-erythroid-2-related factor 2 signaling in diabetic cardiomyopathy (Review)
por: Wu, Xia, et al.
Publicado: (2021)

Suppression of Rat Oral Carcinogenesis by Agonists of Peroxisome Proliferator Activated Receptor γ
por: McCormick, David L., et al.
Publicado: (2015)

Synergy between peroxisome proliferator‐activated receptor γ agonist and radiotherapy in cancer
por: Huang, Guodong, et al.
Publicado: (2018)

Beyond 2D: effects of photobiomodulation in 3D tissue-like systems
por: Bikmulina, Polina Y., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9ojvnkgg5n0gf09vq6c9f1pa9s